Your shopping cart is currently empty

Vaccinia virus capping enzyme is a transcription initiation factor that functions as a heterodimer composed of D1 (844 aa) and D12 (287 aa) polypeptides, capable of performing all three steps of m7GpppRNA synthesis. It has been widely utilized as a reagent for in vitro capping and for labeling capped RNA.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Vaccinia virus capping enzyme is a transcription initiation factor that functions as a heterodimer composed of D1 (844 aa) and D12 (287 aa) polypeptides, capable of performing all three steps of m7GpppRNA synthesis. It has been widely utilized as a reagent for in vitro capping and for labeling capped RNA. |
| In vitro | Vaccinia virus capping enzyme is involved in the formation of the 5' cap structure and the termination of early transcription. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.